About the Disease
Fabry disease, also known as angiokeratoma corporis diffusum, ceramide trihexosidosis or Anderson-Fabry disease, is the most prevalent lysosomal storage disorder that results from the buildup of globotriaosylceramide, a particular type of fat, in the body’s cells. It is a rare disease that affects multiple systems.
Source: National Institutes of Health
Diagnosis Codes
ICD-10: E75.21
Clinical Trials
If you’ve ever wondered how to sign up for a clinical trial but aren’t sure where to start, visit PAN Foundation’s education hub to learn about safety, compensation, and more. Read real stories from patients who participated in clinical trials, find a clinical trial that matches your interest, and call us to talk to a ComPANion Access Navigator for free, personalized help.
Alliance Partners
Patients can receive free education and support services.
The National Kidney Foundation conducts research and provides education and support for all people affected by kidney disease.

-
Subscribe to news
Sign up to receive PAN news, from helpful articles to action alerts.
Subscribe today -
-